| Date | Form | Description | Docs | XBRL | Pages |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/04/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 3 | Initial statement of beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...